IRF
ACAD icon

IBM Retirement Fund’s Acadia Pharmaceuticals ACAD Stock Holding History

IBM Retirement Fund’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,125
Closed -$221K – 774
2020
Q4 		$221K Buy
+4,125
New +$205K 0.02% 725
2017
Q1 		– Sell
-7,660
Closed -$221K – 346
2016
Q4 		$221K Sell
7,660
-1,432
-16% -$37.9K 0.01% 866
2016
Q3 		$289K Sell
9,092
-39
-0.4% -$1.32K 0.01% 846
2016
Q2 		$296K Buy
+9,131
New +$306K 0.01% 854

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

IBM Retirement Fund's ACAD Position: Q1 2021 in Review

IBM Retirement Fund sold out of Acadia Pharmaceuticals (ACAD) in Q1 2021, closing a stake of 4,125 shares — an estimated $221K sold.

IBM Retirement Fund first reported a position in ACAD in Q2 2016 and held it in 4 quarters. The position peaked at $296K in Q2 2016. 272 funds tracked by Wall St. Rank hold ACAD as of Q1 2021.

  • IBM Retirement Fund reported no remaining Acadia Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • IBM Retirement Fund sold 4,125 Acadia Pharmaceuticals shares in Q1 2021, an estimated $221K.
  • IBM Retirement Fund first reported a position in Acadia Pharmaceuticals in Q2 2016 and held it in 4 quarters.
  • IBM Retirement Fund's Acadia Pharmaceuticals position peaked at $296K in Q2 2016.
  • 272 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2021.

Based on IBM Retirement Fund's 13F filing for Q1 2021, filed 22 Apr 2021.